Market Research Logo

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Bladder Cancer patients study in a new report ‘Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bladder Cancer epidemiology, Bladder Cancer diagnosed patients, and Bladder Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Bladder Cancer derived from epidemiological analysis, percentage of patients diagnosed with Bladder Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Bladder Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Bladder Cancer prevalence, Bladder Cancer diagnosis rate, and Bladder Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Bladder Cancer Patient Flow
  • Bladder Cancer Prevalence
  • Bladder Cancer Diagnosed Patients
  • Bladder Cancer Treated Patients


1. Bladder Cancer: Disease Definition
2. Global Bladder Cancer Patient Flow
2A. Global Bladder Cancer Prevalence
2B. Global Bladder Cancer Diagnosed Patients
2C. Global Bladder Cancer Treated Patients
3. Bladder Cancer Patient Flow in the US
3A. Bladder Cancer Prevalence in the US
3B. Bladder Cancer Diagnosed Patients in the US
3C. Bladder Cancer Treated Patients in the US
4. Bladder Cancer Patient Flow in Europe
4A. Bladder Cancer Prevalence in Europe
4B. Bladder Cancer Diagnosed Patients in Europe
4C. Bladder Cancer Treated Patients in Europe
5. Bladder Cancer Patient Flow in Germany
5A. Bladder Cancer Prevalence in Germany
5B. Bladder Cancer Diagnosed Patients in Germany
5C. Bladder Cancer Treated Patients in Germany
6. Bladder Cancer Patient Flow in France
6A. Bladder Cancer Prevalence in France
6B. Bladder Cancer Diagnosed Patients in France
6C. Bladder Cancer Treated Patients in France
7. Bladder Cancer Patient Flow in Spain
7A. Bladder Cancer Prevalence in Spain
7B. Bladder Cancer Diagnosed Patients in Spain
7C. Bladder Cancer Treated Patients in Spain
8. Bladder Cancer Patient Flow in Italy
8A. Bladder Cancer Prevalence in Italy
8B. Bladder Cancer Diagnosed Patients in Italy
8C. Bladder Cancer Treated Patients in Italy
9. Bladder Cancer Patient Flow in UK
9A. Bladder Cancer Prevalence in UK
9B. Bladder Cancer Diagnosed Patients in UK
9C. Bladder Cancer Treated Patients in UK
10. Bladder Cancer Patient Flow in Japan
10A. Bladder Cancer Prevalence in Japan
10B. Bladder Cancer Diagnosed Patients in Japan
10C. Bladder Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Bladder Cancer Patient Flow, 2016
Table 2: Global Bladder Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Bladder Cancer Patient Flow in the US, 2016
Table 4: Bladder Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Bladder Cancer Patient Flow in Europe, 2016
Table 6: Bladder Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Bladder Cancer Patient Flow in Germany, 2016
Table 8: Bladder Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Bladder Cancer Patient Flow in France, 2016
Table 10: Bladder Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Bladder Cancer Patient Flow in Spain, 2016
Table 12: Bladder Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Bladder Cancer Patient Flow in Italy, 2016
Table 14: Bladder Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Bladder Cancer Patient Flow in UK, 2016
Table 16: Bladder Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Bladder Cancer Patient Flow in Japan, 2016
Table 18: Bladder Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Bladder Cancer Patient Flow, 2016
Figure 2: Global Bladder Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Bladder Cancer Patient Flow in the US, 2016
Figure 4: Bladder Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Bladder Cancer Patient Flow in Europe, 2016
Figure 6: Bladder Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Bladder Cancer Patient Flow in Germany, 2016
Figure 8: Bladder Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Bladder Cancer Patient Flow in France, 2016
Figure 10: Bladder Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Bladder Cancer Patient Flow in Spain, 2016
Figure 12: Bladder Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Bladder Cancer Patient Flow in Italy, 2016
Figure 14: Bladder Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Bladder Cancer Patient Flow in UK, 2016
Figure 16: Bladder Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Bladder Cancer Patient Flow in Japan, 2016
Figure 18: Bladder Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report